Reverse transcriptase inhibitors promote the remodelling of nuclear architecture and induce autophagy in prostate cancer cells.
Cancer Lett. 2020 May 28;478:133-145. doi: 10.1016/j.canlet.2020.02.029. Epub 2020 Feb 26.
Cancer Lett. 2020.
PMID: 32112906